FindTrial
Sign In

The Effectiveness of Idazoxan in Treating TRD

Status
Withdrawn
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00294944
Enrollment
Unknown
Registered
2006-02-22
Start date
Unknown
Completion date
Unknown
Last updated
2008-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Brief summary

Assessing the effectiveness of Idazoxan as a treatment for depressive patients who did not respond to treatment with SSRI

Interventions

DRUGIdazoxan

Sponsors

Sheba Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years

Inclusion criteria

* MDD patients * Did not respond to at least one treatment of 4-6 weeks of SSRI in adequate dose * In or out patients

Exclusion criteria

* Psychotic symptoms

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026